|
|
Å׵θ®
|
|
 |
fDRzgSYmFkuXRu |
 |
561 |
|
 |
| I'd like to open an account https://www.autoshowsonline.com/stmap_18lfj5c.html drug-from-canada.com In any case, the analyst said he expects Copaxone sales tofall to about $3.8 billion this year because of competition fromnew oral treatments for multiple sclerosis, including BiogenIdec's Tecfidera and Sanofi SA's Aubagio, andto fall to $3.4 billion in 2014 for the same reason, even if nogenerics are introduced. |
 |
 |
Denver |
 |
2020-04-27 11:27:26 |
|
|
|
|
|
|
|
|
|